Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study
Authors:
Open Access
- 27 January 2004
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 132 (1) , 11-18
Abstract
A serological prevalence survey was carried out in Luxembourg during 2000–2001 to determine the antibody status of the Luxembourg population against vaccine-preventable infections. Blood samples of children and adolescents were collected prospectively in randomly selected schools. Samples of adults were obtained through volunteer patients of the national health laboratory or of the mandatory pre-nuptial test. Measles, mumps and rubella (MMR) virus antibody concentrations were measured using commercial ELISA tests. Age-standardized prevalence of measles, mumps and rubella virus antibodies was found to be 96·58, 75·40 and 95·69% respectively. Significant age-dependence of serology was observed for all three infections, with study participants born after the introduction of the MMR vaccine experiencing a gradual decline of antibodies following vaccination in childhood. Older study participants who were more likely to have antibodies from natural infection had consistently higher titres than younger individuals. Present vaccination coverage with MMR appears to be sufficient to prevent large local outbreaks of measles and rubella, but probably not mumps.Keywords
This publication has 9 references indexed in Scilit:
- Modelling measles re-emergence as a result of waning of immunity in vaccinated populationsVaccine, 2003
- Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated populationEpidemiology and Infection, 2000
- Non-participation in a population-based seroprevalence study of vaccine-preventable diseasesEpidemiology and Infection, 2000
- Modeling the Impact of Subclinical Measles Transmission in Vaccinated Populations with Waning ImmunityAmerican Journal of Epidemiology, 1999
- Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverageVaccine, 1999
- Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programmeVaccine, 1998
- Approximating statistical functions by using fractional polynomial regressionJournal of the Royal Statistical Society: Series D (The Statistician), 1997
- Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-upVaccine, 1995
- Two Doses of MMR Vaccine—Sufficient to Eradicate Measles, Mumps and Rubella?Scandinavian Journal of Social Medicine, 1988